Evidence map›Paper›PMID 38264228›Full record

ArticleDiabetology international2024

Life-threatening coronary vasospasm in patients with type 2 diabetes with SGLT2 inhibitor-induced euglycemic ketoacidosis: a report of two consecutive cases.

Junko Kawahara, Bunji Kaku, Kunimasa Yagi, Naotaka Kitagawa, Maki Yokoyama, Yusuke Wakabayashi, Satoko Senda, Hiroyuki Takata, Yoshio Hiraiwa

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Junko Kawahara *Department of Internal Medicine, Toyama Red Cross Hospital, Toyama, Toyama Japan.
Bunji Kaku *Department of Internal Medicine, Toyama Red Cross Hospital, Toyama, Toyama Japan.
Kunimasa Yagi *Department of Internal Medicine, Kanazawa Medical University Hospital, 1-1 Daigaku, Uchinada, Ishikawa 920-0293 Japan.ORCID 0000-0002-6805-6428
Naotaka KitagawaDepartment of Internal Medicine, Toyama Red Cross Hospital, Toyama, Toyama Japan.
Maki YokoyamaDepartment of Internal Medicine, Toyama Red Cross Hospital, Toyama, Toyama Japan.
Yusuke WakabayashiDepartment of Internal Medicine, Toyama Red Cross Hospital, Toyama, Toyama Japan.
Satoko SendaDepartment of Internal Medicine, Toyama Red Cross Hospital, Toyama, Toyama Japan.
Hiroyuki TakataDepartment of Internal Medicine, Toyama Red Cross Hospital, Toyama, Toyama Japan.
Yoshio HiraiwaDepartment of Internal Medicine, Toyama Red Cross Hospital, Toyama, Toyama Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Euglycemic diabetic ketoacidosis (eDKA) has emerged as an adverse event associated with sodium-glucose transporter-2 inhibitors (SGLT2i). We present two consecutive cases of SGLT2i-induced eDKA, both manifested as life-threatening coronary vasospastic angina (VSA). Case 1: A 64-year-old male overweight patient with type 2 diabetes (BMI 28.2 kg/m

Indexed as

AcetylcholineCoronary vasospastic anginaEuglycemic diabetic ketoacidosisSGLT2 inhibitor

Identifiers

PMID38264228
PMCPMC10800321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.